Supplemental Information to Condensed Consolidated Statements of Cash Flows (Detail) - USD ($) $ in Thousands			12 Months Ended
		Apr. 14, 2021	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Schedule Of Cash Flow Supplemental [Line Items]
Cash paid for interest			$ 108,152	$ 102,859	$ 93,907
Cash paid (refunds received) for income taxes, net			(136,512)	(116,916)	88,670
Cash deposited in restricted accounts	[1]		11,920	13,847
Noncash investing and financing activities:
Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment	[2]		20,100	(13,259)	22,013
Theatre properties acquired under finance leases			725		21,535
Theatre properties acquired as distribution from equity investee (see Note 9)				102,719
Investment in NCM – receipt of common units (see Note 8)		$ (10,237)	10,237	3,620	1,552
Dividends Accrued On Unvested Restricted Stock Unit Awards			4	(256)	(670)
NCM
Noncash investing and financing activities:
Interest expense - NCM (see Note 8)			$ (23,612)	$ (23,595)	$ (28,624)

[1] Funds are held as collateral for letters of credit associated with certain of the Company’s international subsidiary loans. See further discussion in Note 13.

[2] Additions to theatre properties and equipment included in accounts payable as of December 31, 2020 and 2021 were $28,250 and $8,150, respectively.